These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 87420)

  • 1. Tumor antigens as inappropriately expressed normal alloantigens.
    Russell JH; Ginns LC; Terres G; Eisen HN
    J Immunol; 1979 Mar; 122(3):912-9. PubMed ID: 87420
    [No Abstract]   [Full Text] [Related]  

  • 2. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    Parmiani G; Ballinari D; Sensi ML
    J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytolytic T lymphocytes recognize alloantigens on schistosomula of Schistosoma mansoni, but fail to induce damage.
    Butterworth AE; Vadas MA; Martz E; Sher A
    J Immunol; 1979 Apr; 122(4):1314-21. PubMed ID: 312837
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell antigen recognition.
    Perry LL; Greene MI
    J Immunol; 1980 Aug; 125(2):738-48. PubMed ID: 6967088
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
    Braun DP; Dray S
    Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity.
    Kaplan AM; Bear HD; Kirk L; Cummins C; Mohanakumar T
    J Immunol; 1978 Jun; 120(6):2080-5. PubMed ID: 659893
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A syngeneic anti tumor serum recognizing a complex H-2 alloantigen.
    Garrido F; Perez M; Torres MD; Garcia-Olivares E; Ivanyi P; Schirrmacher V
    Immunobiology; 1979 Aug; 156(1-2):110-20. PubMed ID: 540966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.
    Giorgi JV; Warner NL
    J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactive cytotoxic T lymphocytes from aged mice express increased lysis of autologous and third-party target cells.
    Kruisbeek AM; Steinmeier FA
    J Immunol; 1980 Aug; 125(2):858-64. PubMed ID: 6156216
    [No Abstract]   [Full Text] [Related]  

  • 14. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC-coded unique alloantigens and antitumor immunity.
    Martin WJ
    Transplant Proc; 1981 Dec; 13(4):1837-40. PubMed ID: 7036480
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship of alloreactivity to syngeneic tumor immunity.
    Greene MI; Perry LL
    Transplant Proc; 1980 Mar; 12(1):80-6. PubMed ID: 6154362
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype.
    Steinmuller D; Tyler JD; David CS
    J Immunol; 1981 May; 126(5):1747-53. PubMed ID: 6452477
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens.
    Theofilopoulos AN; Shawler DL; Balderas RS; Elder JH; Katz DH; Dixon FJ
    J Immunol; 1981 Mar; 126(3):1154-9. PubMed ID: 6161961
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps.
    Fan J; Ahmed A; Bonavida B
    J Immunol; 1980 Dec; 125(6):2444-53. PubMed ID: 6159409
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens.
    Williamson JS; Streilein JW
    Reg Immunol; 1988; 1(1):15-23. PubMed ID: 2978942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.